装有贝瓦西祖马布的CalliSpheres®支气管动脉化学栓塞,结合免疫疗法和针对性治疗,治疗晚期肺腺癌
Haitao Liu1,2, Yahua Li1, Zongming Li1
1Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Frontiers in pharmacology
|June 7, 2023
概括
结合免疫疗法和向治疗的贝瓦西祖马布加载药物排泄的支气管动脉化学栓塞 (DEB-BACE) 对肺腺癌有希望. 这种创新的治疗方法提供了耐受性良好的方法,鼓励疾病控制和生存率.
科学领域:
- 在瘤学瘤学.
- 干预性放射学 干预性放射学
- 药理学 药理学是指药理学的学科.
背景情况:
- 药物排泄支气管动脉化学栓塞 (DEB-BACE) 是一种针对药物输送和栓塞的新兴系统.
- 贝瓦西祖马布 (BEV) 结合化疗已在晚期非小细胞肺癌中显示出有效性.
- 在肺腺癌 (LUAD) 中,带有BEV的DEB-BACE与免疫疗法和向治疗的作用需要研究.
研究的目的:
- 评估贝瓦齐祖马布加载CalliSpheres®支气管动脉化学栓塞 (DEB-BACE) 结合免疫治疗和针对性治疗对LUAD患者的疗效和安全性.
主要方法:
- 九名LUAD患者接受了带有BEV的CalliSpheres® BACE,并接受免疫治疗和向治疗.
- 主要终点包括疾病控制率 (DCR) 和客观反应率 (ORR).
- 二级终点是6个月和12个月的整体存活率 (OS),通过不良事件评估安全性.
主要成果:
- 分别在77.8%和22.2%的患者中观察到部分反应和稳定疾病.
- 客观响应率 (ORR) 从1个月的77.8%到12个月的33.3%.
- 在6个月和12个月的总生存率分别为77.8%和66.7%,没有严重的不良事件.
结论:
- 装有BEV的CalliSpheres® DEB-BACE与免疫疗法和向治疗相结合,在LUAD中显示出有希望的疗效.
- 治疗方案耐受性很好,这表明了有利的安全性.
- 这种多模式的方法代表了LUAD治疗策略的潜在进步.
更多相关视频
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013
10.4K
06:15Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
27.4K
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Cancer Vaccines
435
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
435
